Adalvo Secures First EU Approval For Victoza Rival

After Liraglutide Nod, Company Also Expects Ozempic Approvals In 2024 And 2025

 
• By Adam Zamecnik
  
An image of a semaglutide pen
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products